Orchestra BioMed Hldgs (OBIO) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Orchestra BioMed Hldgs (OBIO) stock.

Latest Upgrades and Downgrades for Orchestra BioMed Hldgs Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$10→$11
—	BTIG	Marie Thibault	Upgrade	Neutral→Buy	$10
—	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$9→$10
—	B. Riley Securities	Kyle Bauser	PT Cut	Buy	$12→$10
—	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$10
—	Barclays	Matt Miksic	PT Raise	Overweight	$12→$13
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	Barclays	Matt Miksic	PT Raise	Overweight	$11→$12
—	TD Cowen	Joshua Jennings	Initiate	Buy	$15
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	Barclays	Matt Miksic	PT Cut	Overweight	$12→$11
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$12→$10
—	BTIG	Marie Thibault	Downgrade	Buy→Neutral	—
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	Barclays	Matt Miksic	PT Cut	Overweight	$16→$12
—	Chardan Capital	Keay Nakae	Maintained	Buy	$20
—	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$14→$12

Analyst Ratings News

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.

Avi Kapoor

This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Analysts upgraded SFNC, OBIO, and more.

Avi Kapoor

PRO
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

Piper Sandler analyst Matt O'Brien reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight and raises the price target from $9 to $10.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

B. Riley Securities analyst Kyle Bauser maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and maintains $10 price target.

Benzinga Newsdesk

Orchestra BioMed Holdings Inc

Orchestra BioMed Hldgs (OBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Orchestra BioMed Hldgs Stock

Orchestra BioMed Hldgs (OBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Orchestra BioMed Hldgs Stock

Analyst Ratings News

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

PRO
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PRO
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PRO
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

PRO
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PRO
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PRO
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

Orchestra BioMed Holdings Inc

Orchestra BioMed Hldgs (OBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Orchestra BioMed Hldgs Stock

Orchestra BioMed Hldgs (OBIO) Stock Price Target 2026

Latest Upgrades and Downgrades for Orchestra BioMed Hldgs Stock

Analyst Ratings News

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

PROBTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PROPiper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PROB. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PROHC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

PROBTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PROPiper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PROB. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PROHC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

PRO
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PRO
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PRO
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

PRO
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

PRO
Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

PRO
B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target